艾滋病毒-1疫苗研究的进展和挑战:全面概述
Alex C Boomgarden1, Chitra Upadhyay1
1Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Vaccines
|February 26, 2025
概括
开发一种有效的HIV-1疫苗是具有挑战性的,因为病毒的多样性和延迟. 像马赛克和mRNA疫苗这样的创新策略是有希望的,但需要多方面的方法来实现对HIV-1的全球成功.
科学领域:
- 生物医学研究的研究.
- 疫苗学 疫苗学 疫苗学
- 传染病 传染病 传染病
背景情况:
- 艾滋病毒-1疫苗开发面临重大障碍,包括病毒遗传多样性,快速突变和潜伏储存库的建立.
- 尽管在了解HIV-1生物和病原发生方面取得了进展,但有效的疫苗策略仍然难以捉摸.
研究的目的:
- 审查目前在HIV-1疫苗开发中的创新方法.
- 讨论这些策略对其他疫苗研究的影响,例如COVID-19,流感和寨卡病毒.
- 突出克服HIV-1疫苗设计局限性的挑战和方法.
主要方法:
- 对马赛克疫苗和用于诱导广泛中和抗体的mRNA技术的当前研究进行审查.
- 对创新的HIV-1疫苗策略的临床前和临床成功的分析.
- 检查阻碍HIV-1疫苗有效性的因素,包括病毒多样性和延迟.
主要成果:
- 像马赛克和mRNA疫苗这样的创新方法已经显示出希望,但取得了适度的疗效 (约30%).
- 为了克服开发全球HIV-1疫苗的障碍,必须采取多方面的战略.
- 技术的进步使得有效的HIV-1疫苗的目标更加接近.
结论:
- 持续的研究和创新技术对于开发全球HIV-1疫苗至关重要.
- 艾滋病毒-1疫苗开发的进展可以为其他传染病的研究提供信息和利益.
- 克服病毒挑战需要全面和多方面的科学方法.
更多相关视频
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.3K
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
相关概念视频
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccine Production
152
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
152
Human Virome
54
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
54
